• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年女性乳腺癌的趋势:过去十年雌激素和人表皮生长因子受体2(HER2)亚型的发展情况

Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years.

作者信息

Palshof Frederik K, Mørch Lina S, Jensen Maj-Britt R, Storm Hans H, Kroman Niels, Tvedskov Tove H F

机构信息

The Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark; Department of Breast Surgery, Gentofte Hospital, Gentofte Hospitalsvej 1, 2900 Hellerup, Denmark.

The Danish Cancer Society, Danish Cancer Institute, Strandboulevarden 49, 2100 Copenhagen Ø, Denmark.

出版信息

Breast. 2025 Feb;79:103860. doi: 10.1016/j.breast.2024.103860. Epub 2024 Dec 15.

DOI:10.1016/j.breast.2024.103860
PMID:39693708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11722930/
Abstract

BACKGROUND

Increasing life expectancy increases breast cancer (BC) rates in elderly, where better health allows for improved tolerance of treatments. We assessed trends in BC incidence of tumor subtypes for women with focus on the elderly.

METHODS

Changes in BC incidence in women by age from 2012 to 2021 were assessed using data from the Nordic countries. We calculated the incidence of BC subtypes by age group using data from the Danish Breast Cancer Group (DBCG) database. We used generalized linear models assuming a Poisson distribution.

RESULTS

In the Nordic countries, 205 305 women were diagnosed with BC between 2012 and 2021. In Denmark, 50 858 BC patients were diagnosed between 2012 and 2022, identified with tumor characteristics. Incidence of BC among women aged 80+ increased significantly across the Nordic Countries, with 1.24 % per year (95 % CI: 0.07 %: 2.41 %). In Denmark, in the 80+ group, the ER+/HER2- subtype had the highest increase, with 1.98 % per year (95 % CI: 1.10 %: 2.87 %).

CONCLUSION

Across the Nordic countries, incidence of BC in women aged 80+ increased. In Denmark, rising incidence of BC is driven by the ER+/HER2- subtype in the 80+ group, which has the best prognosis and gentle treatments. More elderly BC patients will require treatment and follow-up in the future.

摘要

背景

预期寿命的增加导致老年女性乳腺癌(BC)发病率上升,因为更好的健康状况使她们对治疗的耐受性提高。我们评估了以老年女性为重点的肿瘤亚型的BC发病率趋势。

方法

利用北欧国家的数据评估了2012年至2021年按年龄划分的女性BC发病率变化。我们使用丹麦乳腺癌组(DBCG)数据库的数据计算了各年龄组的BC亚型发病率。我们使用了假定为泊松分布的广义线性模型。

结果

在北欧国家,2012年至2021年期间有205305名女性被诊断为BC。在丹麦,2012年至2022年期间有50858名BC患者被诊断,并确定了肿瘤特征。北欧国家80岁及以上女性的BC发病率显著上升,每年上升1.24%(95%CI:0.07%:2.41%)。在丹麦,80岁及以上年龄组中,ER+/HER2-亚型的发病率上升最高,每年上升1.98%(95%CI:1.10%:2.87%)。

结论

在北欧国家,80岁及以上女性的BC发病率上升。在丹麦,80岁及以上年龄组中BC发病率的上升是由ER+/HER2-亚型推动的,该亚型预后最佳且治疗温和。未来将有更多老年BC患者需要治疗和随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/1edc53057688/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/74e437e2fec2/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/9e390d1d46c7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/1edc53057688/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/74e437e2fec2/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/9e390d1d46c7/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e003/11722930/1edc53057688/gr2.jpg

相似文献

1
Trends in breast cancer among elderly women: Development in estrogen and HER2 subtypes in the last ten years.老年女性乳腺癌的趋势:过去十年雌激素和人表皮生长因子受体2(HER2)亚型的发展情况
Breast. 2025 Feb;79:103860. doi: 10.1016/j.breast.2024.103860. Epub 2024 Dec 15.
2
Breast cancer-specific survival by molecular subtype in different age groups of women in Scotland.苏格兰不同年龄组女性乳腺癌分子亚型的特异性生存率。
Breast Cancer Res. 2025 Apr 22;27(1):59. doi: 10.1186/s13058-025-02012-x.
3
Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.丹麦雌激素受体阳性和阴性乳腺癌趋势的差异以及病因异质性。
Int J Cancer. 2013 Nov;133(9):2201-6. doi: 10.1002/ijc.28222. Epub 2013 Jun 13.
4
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.阿尔及利亚女性分子乳腺癌亚型的分布及其与临床和肿瘤特征的相关性:一项基于人群的研究。
Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398.
5
Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort.7 年随访后年轻和老年女性全国队列中临床亚型的乳腺癌特异性生存。
Int J Cancer. 2019 Mar 15;144(6):1251-1261. doi: 10.1002/ijc.31950. Epub 2018 Dec 3.
6
The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.乳腺癌亚型对局部晚期乳腺癌患者蒽环类新辅助化疗反应的影响。
J BUON. 2018 Sep-Oct;23(5):1273-1280.
7
Survival outcomes for HER2-low breast cancer: Danish national data.HER2 低表达乳腺癌的生存结局:丹麦全国数据。
Acta Oncol. 2024 Nov 14;63:878-886. doi: 10.2340/1651-226X.2024.41280.
8
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.原发性全身化疗后丰富的肿瘤浸润淋巴细胞预示着雌激素受体阳性/HER2 阴性乳腺癌预后不良。
Breast Cancer Res Treat. 2018 Feb;168(1):135-145. doi: 10.1007/s10549-017-4575-z. Epub 2017 Nov 22.
9
Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.白人女性乳腺癌生存中乳腺癌亚型、Ki-67 增殖指数、年龄和病理肿瘤特征的预后价值。
Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.
10
A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.泰国南部女性中激素受体阳性和 HER2 阳性乳腺癌亚型的快速增加:宋卡的一项基于人群的研究。
PLoS One. 2022 Mar 28;17(3):e0265417. doi: 10.1371/journal.pone.0265417. eCollection 2022.

本文引用的文献

1
Multicenter Study on Breast Cancer in the Geriatric Population: Insights for Effective Treatment Strategies.老年人群乳腺癌多中心研究:有效治疗策略的见解
Cureus. 2024 Mar 30;16(3):e57253. doi: 10.7759/cureus.57253. eCollection 2024 Mar.
2
Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors.2050 年消除可改变风险因素情景下可避免的乳腺癌、前列腺癌、肺癌和结直肠癌病例数。
Sci Rep. 2024 Apr 13;14(1):8577. doi: 10.1038/s41598-024-59314-x.
3
High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients.
HER2 低表达乳腺癌评估中实验室间的高度变异性:丹麦 50714 例患者的全国登记研究。
Breast Cancer Res. 2023 Nov 9;25(1):139. doi: 10.1186/s13058-023-01739-9.
4
Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis.生殖风险因素与乳腺癌分子亚型的关联:系统评价和荟萃分析。
BMC Cancer. 2023 Jul 10;23(1):644. doi: 10.1186/s12885-023-11049-0.
5
Breast cancer screening programmes and self-reported mammography use in European countries.欧洲国家的乳腺癌筛查项目及自我报告的乳房X光检查使用情况。
Int J Cancer. 2023 Jun 15;152(12):2512-2527. doi: 10.1002/ijc.34494. Epub 2023 Mar 17.
6
Adjuvant Treatment of Elderly Breast Cancer Patients: Offer the Best Chances of Cure.老年乳腺癌患者的辅助治疗:提供最佳治愈机会。
Breast Care (Basel). 2022 Feb;17(1):71-80. doi: 10.1159/000513708. Epub 2021 Mar 4.
7
Pooled Analysis of Nine Cohorts Reveals Breast Cancer Risk Factors by Tumor Molecular Subtype.九项队列研究的汇总分析揭示了肿瘤分子亚型的乳腺癌危险因素。
Cancer Res. 2018 Oct 15;78(20):6011-6021. doi: 10.1158/0008-5472.CAN-18-0502. Epub 2018 Sep 5.
8
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学院临床实践指南的重点更新。
J Clin Oncol. 2018 Jul 10;36(20):2105-2122. doi: 10.1200/JCO.2018.77.8738. Epub 2018 May 30.
9
The clinical database and implementation of treatment guidelines by the Danish Breast Cancer Cooperative Group in 2007-2016.丹麦乳腺癌协作组2007 - 2016年的临床数据库及治疗指南实施情况。
Acta Oncol. 2018 Jan;57(1):13-18. doi: 10.1080/0284186X.2017.1404638. Epub 2017 Dec 5.
10
Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.爱尔兰不同雌激素受体特异性乳腺癌的趋势(2004 - 2013年):收集来自西方独立人群的数据提供了病因线索。
Eur J Cancer. 2017 Nov;86:326-333. doi: 10.1016/j.ejca.2017.08.031. Epub 2017 Oct 23.